Nasdaq

BD Submits PMA Supplement To FDA For ThinPrep Pap Test PreservCyt Solution Vial - Quick Facts

(RTTNews) - Medical technology company Becton, Dickinson and Co. or BD (BDX) announced Wednesday that it has submitted a pre-market approval (PMA) supplement to the U.S. Food and Drug Administration ...
Nasdaq

BD Submits Pre-Market Approval Supplement to FDA to Enable ThinPrep® Pap Test™ PreservCyt® Solution to be Used with the BD Onclarity™ HPV Assay

FRANKLIN LAKES, N.J., Sept. 23, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has submitted a pre-market ...
Pharmabiz

BD introduces new liquid based cytology technique to enable accurate cervical cancer screening

BD Life Sciences-Diagnostic Systems, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, announced the launch of BD SurePath Direct to Slide. It is a liquid ...